Parallax Volatility Advisers’s Arcutis Biotherapeutics ARQT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-50,039
| Closed | -$697K | – | 563 |
|
|
2024
Q4 | $697K | Buy |
50,039
+39
| +0.1% | +$543 | ﹤0.01% | 381 |
|
|
2024
Q3 | $465K | Buy |
50,000
+803
| +2% | +$7.47K | ﹤0.01% | 421 |
|
|
2024
Q2 | $458K | Sell |
49,197
-4,328
| -8% | -$40.3K | ﹤0.01% | 400 |
|
|
2024
Q1 | $530K | Sell |
53,525
-221,739
| -81% | -$2.2M | ﹤0.01% | 366 |
|
|
2023
Q4 | $889K | Sell |
275,264
-7,170
| -3% | -$23.2K | ﹤0.01% | 330 |
|
|
2023
Q3 | $1.5M | Buy |
282,434
+22,578
| +9% | +$120K | ﹤0.01% | 251 |
|
|
2023
Q2 | $2.48M | Buy |
259,856
+33,543
| +15% | +$320K | 0.01% | 196 |
|
|
2023
Q1 | $2.49M | Buy |
226,313
+163,137
| +258% | +$1.79M | 0.01% | 206 |
|
|
2022
Q4 | $935K | Buy |
+63,176
| New | +$935K | ﹤0.01% | 348 |
|